基于CiteSpace的中药治疗慢性萎缩性胃炎文献可视化分析

Abstract
Figure/Table
References (25)
Related Citation (15)

Download: PDF (1678 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To explore the development status, research hotspot, and development trend of traditional Chinese medicine for the treatment of chronic atrophic gastritis (CAG) based on CiteSpace. Methods Literatures on traditional Chinese medicine treatment of CAG collected from China national knowledge infrastructure from January 2000 to April 2020 were retrieved, and CiteSpace software was used to perform visual map analysis of institutions, authors and keywords in the included literatures. Results A total of 1056 articles were included, and the number of published papers showed an increasing trend. The research institutions were mainly concentrated in North, East and South China, including Nanjing University of Chinese Medicine, Guangxi University of Chinese Medicine, Tianjin University of Traditional Chinese Medicine, etc. Inter-institutional cooperation was mainly between the university and its affiliated hospitals, with inter-regional and inter-institutional cooperation was relatively sparse. Wei Muxin, Yuan Hongxia, Yang Jinxiang, Xie Jingri, Lin Shouning were the key researchers, and their collaboration were mainly within the team. The research focuses on the analysis of the etiology and pathogenesis of CAG and prescription, the study of the evaluation of the clinical efficacy of traditional Chinese medicine in the treatment of CAG, and the study of the mechanism of clinical effective prescriptions. Conclusion Research on the treatment of CAG with traditional Chinese medicine has received more and more attention. The phenomenon of weak cooperation between different institutions and their teams needs to be strengthened. The efficacy evaluation methods and the mechanism of famous medicine and prescription in clinical research still need to be explored in depth. On this basis, finding clinically effective protocols for the treatment of CAG with traditional Chinese medicine is the major research hotspot and direction for the future.

Key words： Chronic atrophic gastritis Traditional Chinese medicine CiteSpace Visualization analysis

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	LIU Shan1 FAN Qiongyin2 LIU Xiaoyao1 HU Yujie1 ZHU Peixuan1 SU Zeqi2
	3 WANG Ting2
	3

Cite this article:

LIU Shan1 FAN Qiongyin2 LIU Xiaoyao1 HU Yujie1 ZHU Peixuan1 SU Zeqi2,3 WANG Ting2,3. Visualization analysis of literature on traditional Chinese medicine treatment for chronic atrophic gastritis based on CiteSpace[J]. 中国医药导报, 2021, 18(20): 10-15,20.

URL:

https://www.yiyaodaobao.com.cn/EN/ OR https://www.yiyaodaobao.com.cn/EN/Y2021/V18/I20/10

[1] Chen C. CiteSpace Ⅱ：Detecting and visualizing emerging trends and transient patterns in scientific literature [J]. J Assoc Inf Sci Tech，2006，57（3）：359-377.
[2] 侯剑华，胡志刚.CiteSpace软件应用研究的回顾与展望[J].现代情报，2013，33（4）：99-103.
[3] 李淑红，刘华一，唐艳萍，等.中医药治疗慢性萎缩性胃炎伴癌前病变临床随机对照试验的Meta分析[J].中国中西医结合消化杂志，2017，25（11）：855-861.
[4] 刘伟，潘华峰，王奇，等.健脾益气化瘀解毒法治疗慢性萎缩性胃炎伴癌前病变的系统评价与Meta分析[J].中华中医药杂志，2017，32（11）：5122-5128.
[5] 房静远，杜奕奇，刘文忠，等.中国慢性胃炎共识意见（2017年，上海）[J].胃肠病学，2017，22（11）：670-687.
[6] Pimentel-Nunes P，Lib?覾nio D，Marcos-Pinto R，et al. Management of epithelial precancerous conditions and lesions in the stomach（MAPS Ⅱ）：European Society of Gastrointestinal Endoscopy（ESGE），European Helicobacter and Microbiota Study Group（EHMSG），European Society of Pathology（ESP），and Sociedade Portuguesa de Endoscopia Digestiva（SPED）guideline update 2019 [J]. Endoscopy，2019，51（4）：365-388.
[7] 邹文斌，李兆申.中国胃癌发病率及死亡率研究进展[J].中国实用内科杂志，2014，34（4）：408-415.
[8] 曹毛毛，陈万青.中国恶性肿瘤流行情况及防控现状[J].中国肿瘤临床，2019，46（3）：145-149.
[9] 董颖，杨文君.消化道恶性肿瘤流行病学特征与发病现状分析[J].医学综述，2014，20（3）：429-431.
[10] 黄大未，杨晋翔，魏玥，等.中国南北方地区慢性萎缩性胃炎中医证候对比研究[J].北京中医药大学学报，2013， 36（11）：783-785.
[11] 虎喜成，刘敬霞，田文荣，等.宁夏地区慢性萎缩性胃炎患者中医证候分布特点[J].长春中医药大学学报，2015， 31（3）：538-541.
[12] 徐伟超，许玉龙，张增博，等.基于隐结构模型的名老中医药专家辨证论治京津冀地区慢性萎缩性胃炎用药规律研究[J].中国中药杂志，2020，45（7）：1691-1697.
[13] 张佳艺，丁杰，杜璐瑶，等.中医药治疗慢性萎缩性胃炎概况[J].中医学报，2019，34（12）：2570-2575.
[14] 张声生，唐旭东，黄穗平，等.慢性胃炎中医诊疗专家共识意见（2017）[J].中华中医药杂志，2017，32（7）：3060-3064.
[15] 姚朋华，于青松，谷雨明.基于中医传承辅助系统治疗慢性萎缩性胃炎癌前病变组方分析[J].中国中医药科技，2018，25（2）：297-299.
[16] 杨良俊，李嘉丽，樊湘珍，等.基于因子分析及关联规则的慢性萎缩性胃炎胃癌前病变方药分析[J].中华中医药学刊，2019，37（7）：1642-1645.
[17] 林展宏，郭卫中，王坤.基于数据挖掘技术对中药治疗慢性萎缩性胃炎用药规律的分析[J].新中医，2019，51（8）：32-36.
[18] Tang XD，Zhou LY，Zhang ST，et al. Randomized double-blind clinical trial of Moluodan for the treatment of chronic atrophic gastritis with dysplasia [J]. Chin J Integr Med，2016，22（1）：9-18.
[19] Deng X，Liu ZW，Wu FS，et al. A clinical study of weining granules in the treatment of gastric precancerous lesions [J]. J Tradit Chin Med，2012，32（2）：164-172.
[20] 杨倩，康欣，刘建平，等.化浊解毒汤治疗慢性萎缩性胃炎40例临床观察[J].湖南中医杂志，2020，36（5）：7-9.
[21] 彭雪靖，刘洁.半夏泻心汤对PLGC大鼠胃黏膜P13k/Akt/mTOR通路的影响及其防治研究[J].湖南中医杂志，2018，34（10）：155-157.
[22] 赵唯含，高康丽，李宁飞，等.黄芪、三七及其配伍对慢性萎缩性胃炎大鼠胃组织Hedgehog信号通路的调节作用[J].中华中医药杂志，2016，31（5）：1951-1955.
[23] 蔡甜甜，林琳，潘华峰，等.三七总皂苷激活JNK信号通路对胃癌前病变大鼠胃黏膜组织的保护作用[J].中华中医药杂志，2019，34（12）：5877-5880.
[24] 蔡甜甜，潘华峰，张成哲，等.黄芪甲苷保护胃癌前病变大鼠胃黏膜损伤研究[J].中华中医药杂志，2018，33（9）：4066-4070.
[25] 欧阳一鸣，凌平，李临海，等.铁皮石斛多糖对慢性萎缩性胃炎大鼠的作用及其分子机制研究[J].中国比较医学杂志，2018，28（10）：67-72.